NEW YORK, Sept. 22, 2016
/PRNewswire/ -- The following statement is being issued by Levi
& Korsinsky, LLP:
To: All persons or entities who purchased or otherwise
acquired securities of CytRx Corporation ("CytRx" or the
"Company") (NASDAQ: CYTR) between November 18, 2014 and July
11, 2016.
You are hereby notified that a securities class action
has commenced in the USDC for the Central District of California. If you purchased or otherwise
acquired CytRx securities between November
18, 2014 and July 11, 2016,
your rights may be affected by this action. To get more information
go to:
http://www.zlk.com/pslra/cytrx-corporation.
The complaint alleges that throughout the Class Period,
Defendants made materially false and/or misleading statements
and/or failed to disclose material adverse facts including: (1)
that the clinical hold placed on the Phase 3 trial of aldoxorubicin
for soft tissue sarcomas ("STSs") would prevent sufficient
follow-up for patients involved in the study; (2) that, as a
result, nearly half of all patients would be excluded from the data
since the study was disturbed by a partial clinical hold; (3) that,
in response, CytRx would likely conduct a second analysis; (4) and
that the results of the trial could be materially affected and/or
approval of aldoxorubicin for STS could be delayed.
If you suffered a loss in CytRx you have until September 23, 2016 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn't require that you serve as a lead plaintiff. To
obtain additional information, contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972, or visit
http://www.zlk.com/pslra/cytrx-corporation.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, California, Connecticut, and Washington D.C. The firm's attorneys have
extensive experience representing investors in securities
litigation involving financial fraud, and have recovered hundreds
of millions of dollars for aggrieved shareholders. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY
10004
Tel: (212) 363-7500}
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/deadline-tomorrow-levi--korsinsky-llp-reminds-shareholders-of-cytrx-corporation-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-september-23-2016--cytr-300332591.html
SOURCE Levi & Korsinsky, LLP